Intech Investment Management Reduces Stake in Incyte Corporation

Biopharmaceutical company Incyte sees institutional investor reduce position by 27.7% in Q3

Published on Mar. 2, 2026

Got story updates? Submit your updates here. ›

Intech Investment Management LLC, a major institutional investor, reduced its position in shares of Incyte Corporation (NASDAQ:INCY) by 27.7% in the third quarter of 2025, according to a recent 13F filing with the Securities and Exchange Commission. The fund now owns 50,453 shares of the biopharmaceutical company's stock, valued at $4,279,000 at the end of the reporting period.

Why it matters

Incyte is a prominent biopharmaceutical company focused on developing novel therapies for cancer, autoimmune disorders, and rare diseases. The reduction in Intech's stake could signal a shift in investor sentiment around the company's prospects, though it's just one data point among many that analysts and investors will be watching closely.

The details

Intech Investment Management LLC sold 19,326 shares of Incyte stock during the third quarter, reducing its total position by 27.7%. The firm now holds 50,453 shares of the company, worth $4,279,000 as of the end of the reporting period. Incyte is a Delaware-based biopharmaceutical company known for its flagship product Jakafi, a treatment for myelofibrosis and polycythemia vera.

  • Intech Investment Management LLC reduced its Incyte position in the 3rd quarter of 2025.

The players

Intech Investment Management LLC

A major institutional investor that reduced its stake in Incyte Corporation.

Incyte Corporation

A biopharmaceutical company focused on developing novel therapies for cancer, autoimmune disorders, and rare diseases. Its flagship product is Jakafi.

Got photos? Submit your photos here. ›

The takeaway

This reduction in Intech's Incyte position is a data point that analysts and investors will be closely monitoring as they assess the biopharmaceutical company's prospects. While one institutional investor's move does not necessarily indicate broader trends, it could signal a shift in sentiment around Incyte that warrants further examination.